Divya Gandrala, Krishna Mohan V T. Mallavarapu, Santa Ayyagari, Nisha Hariharan, C. C. K. Naidu, Suseela Kodandapani, Daphne Fonseca, Rakesh Pinninti, Pallavi Suresh Ladda, Kandem Sanath, Rohan Kamlesh Tewani, Nikhil Pathi, Senthil J. Rajappa. "Neoadjuvant intravenous biosimilar pertuzumab and trastuzumab versus subcutaneous pertuzumab/trastuzumab/hyaluronidase (Phesgo) in HER2-positive breast cancer: A real-world comparative study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e12604